StudyFinder

Seasonal influenza vaccine high dose boosting in solid organ transplant recipients

Recruiting

This is a prospective, randomized control trial that will assess neutralizing antibody titers in solid organ transplant (SOT) recipients that receive 2 doses of the high-dose (HD) influenza vaccine during a influenza season. We will evaluate the immunogenicity of 2 doses of the high dose influenza vaccine utilizing neutralizing antibody assays. The control group will receive 1 HD influenza vaccine and a placebo injection.

I'm interested

Male or Female
18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• at least 18 years old
• history of a solid organ transplant (liver, lung, heart, kidney, pancreas) at least 1 year before starting the study
Exclusion Criteria:

• women who are pregnant
• received ATG or carfilzomib in the past 3 months
• received rituximab or basiliximab in the past 3 months
• prednisone dose is greater than 20mg/ day
• history of a severe allergy to influenza vaccine (e.g., Guillain-Barre syndrome, anaphylaxis, or angioedema)
• have received the influenza vaccine for the current season

Infectious Diseases

Clinics and Surgery Center (CSC), influenza, influenza vaccine, Solid organ transplant

Flue Vaccine Study - fluvaccinestudy@umn.edu
Lauren Fontana
STUDY00017687
See this study on ClinicalTrials.gov

Back